Combination therapy with imiquimod, 5-fluorouracil, and tazarotene in the treatment of extensive radiation-induced Bowen's disease of the hands.
Modi
Gunjan
G
Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA.
Jacobs
Aleda A
AA
Orengo
Ida F
IF
McClung
Amy
A
Rosen
Ted
T
D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D001913:Bowen's Disease / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006225:Hand; D006801:Humans; D000077271:Imiquimod; D008297:Male; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000188:drug therapy* / Q000473:pathology; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D012176:Retinoids
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D005472:Fluorouracil; D000077271:Imiquimod; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids